^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
Tris-CAR-T cell therapy
i
Other names: Tris-CAR-T cell therapy, Inverse correlated dual-target, truncated IL7Ra modified CAR -expressing autologous T-lymphocytes
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Beijing Tiantan Hospital, Tasly
Drug class:
CD133-targeted CAR-T immunotherapy, CD44-targeted CAR-T immunotherapy
Related drugs:
